Ladenburg Thalmann initiated coverage on Fortress Biotech with a new price target
$FBIO
Biotechnology: Pharmaceutical Preparations
Health Care
Ladenburg Thalmann initiated coverage of Fortress Biotech with a rating of Buy and set a new price target of $6.00